Project

Over 6 million Americans have Alzheimer's disease (AD) or an AD-related dementia (AD/ADRD). Health care systems (HCS) in all settings (e.g., nursing homes (NHs), community, hospitals, assisted living) struggle to provide high quality, coordinated care that meets the needs of people living with dementia (PLWD) and their care partners (CPs). Scalable and adoptable non-pharmacological interventions that are effective in improving the care delivered to this population are desperately needed. Meeting this challenge demands innovative approaches and robust infrastructures that bring together HCS, researchers, community partners, funders, and regulators focused on this common purpose. Established in September 2019, the National Institute on Aging (NIA) IMbedded Pragmatic Alzheimer's disease (AD) and AD-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory’s mission is to build the nation’s capacity to conduct embedded pragmatic clinical trials (ePCTs) of interventions for PLWD and their CPs.